David Stoll, MD
Dermatology · Santa Monica, CANPI 1457330169
Payments from drug & device makers
Across 330 payments — averaging $6836.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$881K
- Eli Lilly$627K
- Janssen Research & Development, LLC$243K
- LEO Pharma AS$139K
- UCB SA$122K
- Amgen$117K
- plus $127K from 24 others
Across 7 payments — averaging $10,717 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$40K
- UCB SA$30K
- Bausch Health US, LLC$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $880,788 |
| Eli Lilly | 20 | $627,334 |
| Janssen Research & Development, LLC | 34 | $243,441 |
| LEO Pharma AS | 26 | $138,894 |
| UCB SA | 5 | $122,057 |
| Amgen | 30 | $116,675 |
| Bausch Health US, LLC | 12 | $104,450 |
| Dermavant Sciences, Inc. | 12 | $11,240 |
| Arcutis Biotherapeutics, Inc. | 7 | $7,308 |
| Pfizer | 55 | $1,000 |
| Merz North America, Inc. | 3 | $466 |
| Galderma Laboratories, L.p. | 6 | $380 |
| Lilly USA, LLC | 12 | $300 |
| LEO Pharma Inc. | 8 | $266 |
| E.r. Squibb & Sons, L.L.C. | 13 | $239 |
| Johnson & Johnson | 7 | $174 |
| Incyte Corporation | 8 | $155 |
| AbbVie(2 entities) | 6 | $153 |
| Zimmer Biomet | 1 | $126 |
| UCB, Inc. | 4 | $120 |
| EPI Health, LLC | 5 | $103 |
| Sun Pharmaceutical Industries Inc. | 2 | $83 |
| Novartis | 2 | $45 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $39 |
| Organon | 1 | $29 |
| Revance Therapeutics, Inc. | 1 | $27 |
| Mission Pharmacal Company | 2 | $26 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $20 |
How this compares
$2,255,985 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Santa Monica
- Paul YamauchiSanta Monica$7.8M
- Ava ShambanSanta Monica$1.5M
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.